探索拉巴胺素与A549癌细胞中的点受体的相互作用:从分子对接分析的见解
Sanjeev K Ganesh1, C Subathra Devi2,3
1School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Journal of cancer research and clinical oncology
|January 6, 2025
概括
这项研究探讨了拉帕米辛.
科学领域:
- 药理学 药理学 是一个学科.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 拉帕米辛是一种强大的免疫抑制剂和抗癌药物.
- 其精确的作用机制和癌细胞受体相互作用尚未完全阐明.
- 目前的研究主要将拉巴素与mTORC1通路联系起来.
研究的目的:
- 为了识别与拉帕米辛结合的新型癌细胞受体.
- 扩大对拉帕米辛在瘤学中的治疗潜力的理解.
- 为了研究超越mTORC1.1.的拉帕米辛的作用机制.
主要方法:
- 使用细胞培养技术.
- 在研究中进行,包括分子对接和模拟.
- 确定了拉巴胺素与各种受体之间的潜在结合相互作用.
主要成果:
- 拉巴胺证明了与多个受体的结合能力:EGFR,FKBP12,MET,FGFR,ROS1和ALK.
- 这些发现表明相互作用比以前报告的更广泛.
- 确定了拉帕米治疗效果的新目标.
结论:
- 拉巴胺素与mTORC1.1.以外的几个关键癌细胞受体相互作用.
- 这一发现为癌症治疗和药物开发提供了新的途径.
- 对了解拉巴胺在其他疾病 (如自身免疫和神经植物性疾病) 中的作用的潜在影响.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K